DE60004217D1 - Sulphostinanaloga und verfahren zur herstellung von sulphostin und analoga davon - Google Patents
Sulphostinanaloga und verfahren zur herstellung von sulphostin und analoga davonInfo
- Publication number
- DE60004217D1 DE60004217D1 DE60004217T DE60004217T DE60004217D1 DE 60004217 D1 DE60004217 D1 DE 60004217D1 DE 60004217 T DE60004217 T DE 60004217T DE 60004217 T DE60004217 T DE 60004217T DE 60004217 D1 DE60004217 D1 DE 60004217D1
- Authority
- DE
- Germany
- Prior art keywords
- sulphostine
- analog
- producing
- sulphostin
- respeetively
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 1
- AYVBXTCIPLYEBG-NMAPHRJESA-N sulphostin Chemical class N[C@H]1CCCN([P@@](N)(=O)NS(O)(=O)=O)C1=O AYVBXTCIPLYEBG-NMAPHRJESA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/5532—Seven-(or more) membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/568—Four-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Endocrinology (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Superconductors And Manufacturing Methods Therefor (AREA)
- Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
- Nonmetallic Welding Materials (AREA)
- Cosmetics (AREA)
- Saccharide Compounds (AREA)
- Seasonings (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP13585499A JP4121215B2 (ja) | 1999-05-17 | 1999-05-17 | スルフォスチン類縁体、並びにスルフォスチン及びその類縁体の製造方法 |
JP13585499 | 1999-05-17 | ||
PCT/JP2000/003055 WO2000069868A1 (fr) | 1999-05-17 | 2000-05-12 | Analogues de la sulphostine et procede de preparation de la sulphostine et de ses analogues |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60004217D1 true DE60004217D1 (de) | 2003-09-04 |
DE60004217T2 DE60004217T2 (de) | 2004-06-03 |
Family
ID=15161335
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60004217T Expired - Lifetime DE60004217T2 (de) | 1999-05-17 | 2000-05-12 | Sulphostinanaloga und verfahren zur herstellung von sulphostin und analoga davon |
Country Status (8)
Country | Link |
---|---|
US (1) | US6579989B1 (de) |
EP (1) | EP1184388B1 (de) |
JP (1) | JP4121215B2 (de) |
AT (1) | ATE246196T1 (de) |
CA (1) | CA2372068A1 (de) |
DE (1) | DE60004217T2 (de) |
ES (1) | ES2199826T3 (de) |
WO (1) | WO2000069868A1 (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6395767B2 (en) | 2000-03-10 | 2002-05-28 | Bristol-Myers Squibb Company | Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method |
EP1352655A4 (de) * | 2001-01-16 | 2006-11-02 | Nippon Kayaku Kk | Mittel für die knochenmarksuppression und behandlung von infektionskrankheiten und mittel zur erhöhung der leukozytenzahl |
WO2003002531A2 (en) | 2001-06-27 | 2003-01-09 | Smithkline Beecham Corporation | Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
US7531657B2 (en) | 2001-12-17 | 2009-05-12 | Nippon Kayaku Kabushiki Kaisha | Method for preparing sulphostin and analogue thereof or preparation intermediate thereof |
ES2307916T3 (es) * | 2002-03-25 | 2008-12-01 | Nippon Kayaku Kabushiki Kaisha | Nuevo derivado de alfa-amino-n-(diaminofosfinil)lactama. |
JP2004026678A (ja) * | 2002-06-24 | 2004-01-29 | Microbial Chem Res Found | 2型糖尿病治療剤 |
US7355049B2 (en) * | 2003-06-24 | 2008-04-08 | Hoffmann-La Roche Inc. | Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
ATE550656T1 (de) * | 2003-08-20 | 2012-04-15 | Alere San Diego Inc | Verfahren und zusammensetzungen zur messung biologisch aktiver natriuretischer peptide und zur verbesserung ihres therapeutischen potentials |
WO2005027934A1 (ja) * | 2003-09-24 | 2005-03-31 | Nippon Kayaku Kabushiki Kaisha | プロリルオリゴペプチダーゼ阻害剤 |
DOP2006000008A (es) | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
JP4915833B2 (ja) * | 2005-07-01 | 2012-04-11 | 雪印メグミルク株式会社 | ジペプチジルペプチダーゼiv阻害剤 |
PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
UA97479C2 (ru) | 2006-04-11 | 2012-02-27 | Арена Фармасьютикалз, Инк. | Применение g-белок-связанного рецептора (gpcr) для идентификации средств, которые усиливают секрецию глюкозозависимого инсулинотропного пептида (gi) |
JP5148941B2 (ja) * | 2007-07-11 | 2013-02-20 | 公益財団法人微生物化学研究会 | スルフォスチン、及びスルフォスチン関連化合物を有効成分とした抗腫瘍剤 |
EP2108960A1 (de) | 2008-04-07 | 2009-10-14 | Arena Pharmaceuticals, Inc. | Verfahren zur Verwendung eines A G Protein-gekoppelten Rezeptors zur Identifikation von Peptid YY (PYY) Sekretagoga und nützliche Verbindungen zur Behandlung von durch (PYY) Sekretagoga modulierten Zuständen und nützliche Verbindungen zur Behandlung von Zuständen durch PYY |
AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
JP5916387B2 (ja) | 2009-08-03 | 2016-05-11 | 株式会社カネカ | ジペプチジルペプチダーゼ−4阻害剤 |
MX2012011631A (es) | 2010-04-06 | 2013-01-18 | Arena Pharm Inc | Moduladores del receptor gpr119 y el tratamiento de trastornos relacionados con el mismo. |
BR112013008100A2 (pt) | 2010-09-22 | 2016-08-09 | Arena Pharm Inc | "moduladores do receptor de gpr19 e o tratamento de distúrbios relacionados a eles." |
US20140018371A1 (en) | 2011-04-01 | 2014-01-16 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
WO2012145361A1 (en) | 2011-04-19 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145604A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012145603A1 (en) | 2011-04-22 | 2012-10-26 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
CA2979033A1 (en) | 2015-03-09 | 2016-09-15 | Intekrin Therapeutics, Inc. | Methods for the treatment of nonalcoholic fatty liver disease and/or lipodystrophy |
US11253508B2 (en) | 2017-04-03 | 2022-02-22 | Coherus Biosciences, Inc. | PPARy agonist for treatment of progressive supranuclear palsy |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH120357A (de) * | 1956-04-05 | 1927-06-01 | Siemens Schuckertwerke Gmbh | Elektromagnetischer Selbstausschalter, insbesondere in Stöpselform. |
CH570113A5 (de) * | 1972-07-13 | 1975-12-15 | Ciba Geigy Ag | |
US4723002A (en) * | 1986-04-28 | 1988-02-02 | E. R. Squibb & Sons, Inc. | 1-(substituted phosphorous)-azetidinone antibacterials |
US6214340B1 (en) * | 1997-11-18 | 2001-04-10 | Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai | Physiologically active substance sulphostin, process for producing the same, and use thereof |
-
1999
- 1999-05-17 JP JP13585499A patent/JP4121215B2/ja not_active Expired - Fee Related
-
2000
- 2000-05-12 CA CA002372068A patent/CA2372068A1/en not_active Abandoned
- 2000-05-12 US US10/009,707 patent/US6579989B1/en not_active Expired - Fee Related
- 2000-05-12 ES ES00925639T patent/ES2199826T3/es not_active Expired - Lifetime
- 2000-05-12 WO PCT/JP2000/003055 patent/WO2000069868A1/ja active IP Right Grant
- 2000-05-12 DE DE60004217T patent/DE60004217T2/de not_active Expired - Lifetime
- 2000-05-12 EP EP00925639A patent/EP1184388B1/de not_active Expired - Lifetime
- 2000-05-12 AT AT00925639T patent/ATE246196T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP2000327689A (ja) | 2000-11-28 |
WO2000069868A1 (fr) | 2000-11-23 |
EP1184388A4 (de) | 2002-10-16 |
JP4121215B2 (ja) | 2008-07-23 |
EP1184388B1 (de) | 2003-07-30 |
EP1184388A1 (de) | 2002-03-06 |
CA2372068A1 (en) | 2000-11-23 |
ES2199826T3 (es) | 2004-03-01 |
DE60004217T2 (de) | 2004-06-03 |
ATE246196T1 (de) | 2003-08-15 |
US6579989B1 (en) | 2003-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60004217D1 (de) | Sulphostinanaloga und verfahren zur herstellung von sulphostin und analoga davon | |
ATE160341T1 (de) | Benzolsulfonamid-derivate und verfahren zur herstellung | |
IL140554A0 (en) | Oxamyl derivatives and pharmaceutical compositions containing the same | |
ATE120644T1 (de) | Verwendung von 1,3-oxathiolanalogen von nukleosiden zur herstellung eines arzneimittels zur behandlung von hepatitis-b. | |
ATE302180T1 (de) | Zwischenprodukte zur herstellung von non-peptiden retroviralproteasehemmenden verbindungen | |
ATE502932T1 (de) | Makrocyclische analoga und verfahren zu ihrer verwendung und herstellung | |
ATE163645T1 (de) | Eintopfverfahren zur herstellung von 3- chinoloncarbonsäurederivaten | |
ATE142641T1 (de) | Neue peptid-verbindungen und verfahren zur herstellung davon | |
NO20051282L (no) | Antitumorale analoger av lamellariner. | |
DE69231815D1 (de) | Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren | |
DE69431035T2 (de) | 2-Phenyl-3-Azoylbenzothiophene zur Erhöhung der Thrombomodulin Expression | |
DE59300176D1 (de) | 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen. | |
FI935800A0 (fi) | Antidepressiva och mot Parkisons sjukdom verksamma foereningar | |
EP1362844A4 (de) | Benzylaminanalogon | |
EP0587188A3 (de) | Aryl und Heteroaryl substituierte Propenamid Derivate | |
NO173991C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 1,2,5-ditiazocin-derivater | |
DE60224884D1 (de) | Verfahren zur herstellung von 3, 3', 6, 6'-tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'-tetraalkylen-5, 5'-dihalo-2, 2' biphenolen | |
DK0554794T3 (da) | Aminobenzoesyrederivater | |
DK0551844T3 (da) | Svovlholdige galdesyrederivater | |
DE602004028799D1 (en) | Oligosaccharidderivat | |
ATE186912T1 (de) | Carbamoylpyrrolidon-derivate zur behandlung von depressionen und cerebrovasculären störungen | |
ATE122352T1 (de) | 3-(3-ethyl-1,2,4-oxadiazol-5-yl)-1- azabicycloheptan, verfahren zu seiner herstellung und dieses enthaltende pharmazeutische zubereitungen. | |
DE69229017D1 (de) | Glyceraldehyd-3-pentanid und Verfahren zu ihrer Herstellung | |
DE69520554D1 (de) | Verfahren zur herstellung von indolocarbazol-derivaten |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |